[1]
|
Liu, S., Feng, X., Jin, R. and Li, G. (2018) Tissue Plasminogen Activator-Based Nanothrombolysis for Ischemic Stroke. Expert Opinion on Drug Delivery, 15, 173-184. https://doi.org/10.1080/17425247.2018.1384464
|
[2]
|
Yaghi, S., Willey, J.Z., Cucchiara, B., Goldstein, J.N., Gonzales, N.R., Khatri, P., et al. (2017) Treatment and Outcome of Hemorrhagic Transformation after Intravenous Alteplase in Acute Ischemic Stroke: A Scientific Statement for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke, 48, e343-e361. https://doi.org/10.1161/STR.0000000000000152
|
[3]
|
Caldeira, M.V., Salazar, I.L., Curcio, M., Canzoniero, L.M. and Duarte, C.B. (2014) Role of the Ubiquitin-Proteasome System in Brain Ischemia: Friend or Foe? Progress in Neurobiology, 112, 50-69. https://doi.org/10.1016/j.pneurobio.2013.10.003
|
[4]
|
Jeanneret, V. and Yepes, M. (2017) Tissue-Type Plasminogen Activator Is a Homeostatic Regulator of Synaptic Function in the Central Nervous System. Neural Regeneration Research, 12, 362-365. https://doi.org/10.4103/1673-5374.202924
|
[5]
|
Clark, W.M., Wissman, S., Albers, G.W., Jhamandas, J.H., Madden, K.P. and Hamilton, S. (1999) Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours after Symptom Onset. The Atlantis Study: A Randomized Controlled Trial. JAMA, 282, 2019-2026. https://doi.org/10.1001/jama.282.21.2019
|
[6]
|
Gautier, S., Petrault, O., Gele, P., Laprais, M., Bastide, M., Bauters, A., et al. (2003) Involvement of Thrombolysis in Recombinant Tissue Plasminogen Activator-Induced Cerebral Hemorrhages and Effect on Infarct Volume and Postischemic Endothelial Function. Stroke, 34, 2975-2979. https://doi.org/10.1161/01.STR.0000101914.62066.7B
|
[7]
|
Teng, R.S.Y., Tan, B.Y.Q., Miny, S., Syn, N.L., Ho, A.F.W., Ngiam, N.J.H., et al. (2019) Effect of Pretreatment Blood Pressure on Outcomes in Thrombolysed Acute Ischemic Stroke Patients: A Systematic Review and Meta-Analysis. Journal of Stroke and Cerebrovascular Diseases, 28, 906-919. https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.12.008
|
[8]
|
Alvarez-Sabín, J., Molina, C.A., Ribó, M., Arenillas, J.F., Montaner, J., Huertas, R., et al. (2004) Impact of Admission Hyperglycemia on Stroke Outcome after Thrombolysis: Risk Stratification in Relation to Time to Reperfusion. Stroke, 35, 2493-2498. https://doi.org/10.1161/01.STR.0000143728.45516.c6
|
[9]
|
Satumanatpan, N., Tonpho, W., Thiraratananukulchai, N., Chaichanamongkol, P., Lekcharoen, P. and Thiankhaw, K. (2022) Factors Associated with Unfavorable Functional Outcomes after Intravenous Thrombolysis in Patients with Acute Ischemic Stroke. International Journal of General Medicine, 15, 3363-3373. https://doi.org/10.2147/IJGM.S362116
|
[10]
|
Zhang, S., Liao, X.J., Wang, J., Shen, Y., Shi, H.F., Zou, Y., et al. (2022) Temporal Alterations in Pericytes at the Acute Phase of Ischemia/Reperfusion in the Mouse Brain. Neural Regeneration Research, 17, 2247-2252. https://doi.org/10.4103/1673-5374.336876
|
[11]
|
Yang, Y. and Rosenberg, G.A. (2011) Blood-Brain Barrier Breakdown in Acute and Chronic Cerebrovascular Disease. Stroke, 42, 3323-3328. https://doi.org/10.1161/STROKEAHA.110.608257
|
[12]
|
Saleem, S., Wang, D., Zhao, T., Sullivan, R.D. and Reed, G.L. (2021) Matrix Metalloproteinase-9 Expression Is Enhanced by Ischemia and Tissue Plasminogen Activator and Induces Hemorrhage, Disability and Mortality in Experimental Stroke. Neuroscience, 460, 120-129. https://doi.org/10.1016/j.neuroscience.2021.01.003
|
[13]
|
Lu, A., Suofu, Y., Guan, F., Broderick, J.P., Wagner, K.R. and Clark, J.F. (2013) Matrix Metalloproteinase-2 Deletions Protect against Hemorrhagic Transformation after 1 H of Cerebral Ischemia and 23 H of Reperfusion. Neuroscience, 253, 361-367. https://doi.org/10.1016/j.neuroscience.2013.08.068
|
[14]
|
Liu, J., Jin, X., Liu, K.J. and Liu, W. (2012) Matrix Metalloproteinase-2-Mediated Occludin Degradation and Caveolin-1-Mediated Claudin-5 Redistribution Contribute to Blood-Brain Barrier Damage in Early Ischemic Stroke Stage. Journal of Neuroscience, 32, 3044-3057. https://doi.org/10.1523/JNEUROSCI.6409-11.2012
|
[15]
|
Pan, R., Yu, K., Weatherwax, T., Zheng, H., Liu, W. and Liu, K.J. (2017) Blood Occludin Level as a Potential Biomarker for Early Blood Brain Barrier Damage Following Ischemic Stroke. Scientific Reports, 7, Article No. 40331. https://doi.org/10.1038/srep40331
|
[16]
|
Yuan, S., Li, W., Hou, C., Kang, H., Ma, Q., Ji, X., et al. (2021) Serum Occludin Level Combined with Nihss Score Predicts Hemorrhage Transformation in Ischemic Stroke Patients with Reperfusion. Frontiers in Cellular Neuroscience, 15, Article ID: 714171. https://doi.org/10.3389/fncel.2021.714171
|
[17]
|
Wang, L., Wei, C., Deng, L., Wang, Z., Song, M., Xiong, Y., et al. (2018) The Accuracy of Serum Matrix Metalloproteinase-9 for Predicting Hemorrhagic Transformation after Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. Journal of Stroke and Cerebrovascular Diseases, 27, 1653-1665. https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.01.023
|
[18]
|
Challa, S.R., Nalamolu, K.R., Fornal, C.A., Mohandass, A., Mussman, J.P., Schaibley, C., et al. (2022) The Interplay between Mmp-12 and T-Pa in the Brain after Ischemic Stroke. Neurochemistry International, 161, Article ID: 105436. https://doi.org/10.1016/j.neuint.2022.105436
|
[19]
|
Allen, C.L. and Bayraktutan, U. (2009) Oxidative Stress and Its Role in the Pathogenesis of Ischaemic Stroke. International Journal of Stroke, 4, 461-470. https://doi.org/10.1111/j.1747-4949.2009.00387.x
|
[20]
|
Li, H., Wang, Y., Feng, D., Liu, Y., Xu, M., Gao, A., et al. (2014) Alterations in the Time Course of Expression of the Nox Family in the Brain in a Rat Experimental Cerebral Ischemia and Reperfusion Model: Effects of Melatonin. Journal of Pineal Research, 57, 110-119. https://doi.org/10.1111/jpi.12148
|
[21]
|
Tang, X.N., Zheng, Z., Giffard, R.G. and Yenari, M.A. (2011) Significance of Marrow-Derived Nicotinamide Adenine Dinucleotide Phosphate Oxidase in Experimental Ischemic Stroke. Annals of Neurology, 70, 606-615. https://doi.org/10.1002/ana.22476
|
[22]
|
Kuhn, H., Banthiya, S. and van Leyen, K. (2015) Mammalian Lipoxygenases and Their Biological Relevance. Biochimica et Biophysica Acta, 1851, 308-330. https://doi.org/10.1016/j.bbalip.2014.10.002
|
[23]
|
Liu, Y., Zheng, Y., Karatas, H., Wang, X., Foerch, C., Lo, E.H., et al. (2017) 12/15-Lipoxygenase Inhibition or Knockout Reduces Warfarin-Associated Hemorrhagic Transformation after Experimental Stroke. Stroke, 48, 445-451. https://doi.org/10.1161/STROKEAHA.116.014790
|
[24]
|
Xing, Y., Guo, Z.N., Yan, S., Jin, H., Wang, S. and Yang, Y. (2014) Increased Globulin and Its Association with Hemorrhagic Transformation in Patients Receiving Intra-Arterial Thrombolysis Therapy. Neuroscience Bulletin, 30, 469-476. https://doi.org/10.1007/s12264-013-1440-x
|
[25]
|
Carbone, F., Vuilleumier, N., Bertolotto, M., Burger, F., Galan, K., Roversi, G., et al. (2015) Treatment with Recombinant Tissue Plasminogen Activator (R-Tpa) Induces Neutrophil Degranulation in Vitro via Defined Pathways. Vascular Pharmacology, 64, 16-27. https://doi.org/10.1016/j.vph.2014.11.007
|
[26]
|
Maestrini, I., Strbian, D., Gautier, S., Haapaniemi, E., Moulin, S., Sairanen, T., et al. (2015) Higher Neutrophil Counts before Thrombolysis for Cerebral Ischemia Predict Worse Outcomes. Neurology, 85, 1408-1416. https://doi.org/10.1212/WNL.0000000000002029
|
[27]
|
Gori, A.M., Giusti, B., Piccardi, B., Nencini, P., Palumbo, V., Nesi, M., et al. (2017) Inflammatory and Metalloproteinases Profiles Predict Three-Month Poor Outcomes in Ischemic Stroke Treated with Thrombolysis. Journal of Cerebral Blood Flow & Metabolism, 37, 3253-3261. https://doi.org/10.1177/0271678X17695572
|
[28]
|
Gong, P., Liu, Y., Gong, Y., Chen, G., Zhang, X., Wang, S., et al. (2021) The Association of Neutrophil to Lymphocyte Ratio, Platelet to Lymphocyte Ratio, and Lymphocyte to Monocyte Ratio with Post-Thrombolysis Early Neurological Outcomes in Patients with Acute Ischemic Stroke. Journal of Neuroinflammation, 18, Article No. 51. https://doi.org/10.1186/s12974-021-02090-6
|
[29]
|
Sun, Y., Chen, X., Zhang, X., Shen, X., Wang, M., Wang, X., et al. (2017) Β2-Adrenergic Receptor-Mediated Hif-1α Upregulation Mediates Blood Brain Barrier Damage in Acute Cerebral Ischemia. Frontiers in Molecular Neuroscience, 10, Article No. 257. https://doi.org/10.3389/fnmol.2017.00257
|
[30]
|
Kong, L., Ma, Y., Wang, Z., Liu, N., Ma, G., Liu, C., et al. (2021) Inhibition of Hypoxia Inducible Factor 1 by Yc-1 Attenuates Tissue Plasminogen Activator Induced Hemorrhagic Transformation by Suppressing Hmgb1/Tlr4/Nf-κb Mediated Neutrophil Infiltration in Thromboembolic Stroke Rats. International Immunopharmacology, 94, Article ID: 107507. https://doi.org/10.1016/j.intimp.2021.107507
|
[31]
|
Su, E.J., Fredriksson, L., Geyer, M., Folestad, E., Cale, J., Andrae, J., et al. (2008) Activation of Pdgf-Cc by Tissue Plasminogen Activator Impairs Blood-Brain Barrier Integrity during Ischemic Stroke. Nature Medicine, 14, 731-737. https://doi.org/10.1038/nm1787
|
[32]
|
Siao, C.J., Fernandez, S.R. and Tsirka, S.E. (2003) Cell Type-Specific Roles for Tissue Plasminogen Activator Released by Neurons or Microglia after Excitotoxic Injury. Journal of Neuroscience, 23, 3234-3242. https://doi.org/10.1523/JNEUROSCI.23-08-03234.2003
|
[33]
|
Cheon, S.Y., Kim, S.Y., Kam, E.H., Lee, J.H., Kim, J.M., Kim, E.J., et al. (2017) Isoflurane Preconditioning Inhibits the Effects of Tissue-Type Plasminogen Activator on Brain Endothelial Cell in an in Vitro Model of Ischemic Stroke. International Journal of Medical Sciences, 14, 425-433. https://doi.org/10.7150/ijms.18037
|
[34]
|
Roncal, C., Martinez de Lizarrondo, S., Salicio, A., Chevilley, A., Rodriguez, J.A., Rosell, A., et al. (2017) New Thrombolytic Strategy Providing Neuroprotection in Experimental Ischemic Stroke: Mmp10 Alone or in Combination with Tissue-Type Plasminogen Activator. Cardiovascular Research, 113, 1219-1229. https://doi.org/10.1093/cvr/cvx069
|
[35]
|
Murata, Y., Rosell, A., Scannevin, R.H., Rhodes, K.J., Wang, X. and Lo, E.H. (2008) Extension of the Thrombolytic Time Window with Minocycline in Experimental Stroke. Stroke, 39, 3372-3377. https://doi.org/10.1161/STROKEAHA.108.514026
|
[36]
|
Li, Q., Han, X., Lan, X., Hong, X., Li, Q., Gao, Y., et al. (2017) Inhibition of Tpa-Induced Hemorrhagic Transformation Involves Adenosine A2b Receptor Activation after Cerebral Ischemia. Neurobiology of Disease, 108, 173-182. https://doi.org/10.1016/j.nbd.2017.08.011
|
[37]
|
Hu, Y., Zheng, Y., Wang, T., Jiao, L. and Luo, Y. (2022) Vegf, a Key Factor for Blood Brain Barrier Injury after Cerebral Ischemic Stroke. Aging and Disease, 13, 647-654. https://doi.org/10.14336/AD.2021.1121
|
[38]
|
Kanazawa, M., Igarashi, H., Kawamura, K., Takahashi, T., Kakita, A., Takahashi, H., et al. (2011) Inhibition of Vegf Signaling Pathway Attenuates Hemorrhage after Tpa Treatment. Journal of Cerebral Blood Flow & Metabolism, 31, 1461-1474. https://doi.org/10.1038/jcbfm.2011.9
|
[39]
|
Yagi, K., Kitazato, K.T., Uno, M., Tada, Y., Kinouchi, T., Shimada, K., et al. (2009) Edaravone, a Free Radical Scavenger, Inhibits Mmp-9-Related Brain Hemorrhage in Rats Treated with Tissue Plasminogen Activator. Stroke, 40, 626-631. https://doi.org/10.1161/STROKEAHA.108.520262
|
[40]
|
Chen, H., Guan, B., Chen, X., Chen, X., Li, C., Qiu, J., et al. (2018) Baicalin Attenuates Blood-Brain Barrier Disruption and Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke Rats with Delayed T-Pa Treatment: Involvement of Onoo(-)-Mmp-9 Pathway. Translational Stroke Research, 9, 515-529. https://doi.org/10.1007/s12975-017-0598-3
|
[41]
|
Romanos, E., Planas, A.M., Amaro, S. and Chamorro, A. (2007) Uric Acid Reduces Brain Damage and Improves the Benefits of Rt-Pa in a Rat Model of Thromboembolic Stroke. Journal of Cerebral Blood Flow & Metabolism, 27, 14-20. https://doi.org/10.1038/sj.jcbfm.9600312
|
[42]
|
Chen, H., Guan, B., Wang, B., Pu, H., Bai, X., Chen, X., et al. (2020) Glycyrrhizin Prevents Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke with Delayed Thrombolysis through Targeting Peroxynitrite-Mediated Hmgb1 Signaling. Translational Stroke Research, 11, 967-982. https://doi.org/10.1007/s12975-019-00772-1
|